IFN-α treatment increases TP53 phosphorylation in cells from patients with MPN but also increases phosphorylation of STAT1, p21, PUMA, and Bak proteins, which are known to be involved in apoptotic processes [32, 33]. This evidence concerns the gene STAT1 and myeloproliferative neoplasm.